Research and experimental development on natural sciences and engineering
ZELLUNA ASA
Revenue 2024
NOK 6.1m
Operating profit
NOK −278.6m
Equity
NOK 300.4m
Incorporated
2011
Employees
7
Share capital
NOK 26.3m
Roles
Daglig lederNamir Jafar Hassan
Regnskapsfører
Revisor
Styrets lederAnders Tuv
StyremedlemCharlotte Sofie Bergsagel Berg-Svendsen
StyremedlemHans Ivar Robinson
StyremedlemBent Karsten Jakobsen
StyremedlemEva-Lotta Coulter
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| GEVERAN TRADING COMPANY LTD | 9.5% | 2507832.000000 | 2025 |
| INVEN2 AS | 8.4% | 2207034.000000 | 2025 |
| RADFORSK INVESTERINGSSTIFTELSE | 7.5% | 1971886.000000 | 2025 |
| BIRK VENTURE AS | 5.6% | 1473507.000000 | 2025 |
| UBS SWITZERLAND AG | 5.6% | 1465372.000000 | 2025 |
| GJELSTEN HOLDING AS | 5.2% | 1356910.000000 | 2025 |
| MERRILL LYNCH, PIERCE, FENNER & SM | 4.7% | 1238935.000000 | 2025 |
| HELENE SUNDT AS | 4.3% | 1132420.000000 | 2025 |
| SIX SIS AG | 3.4% | 890858.000000 | 2025 |
| RO INVEST AS | 3.0% | 775237.000000 | 2025 |
| J.P. MORGAN SE | 2.7% | 709271.000000 | 2025 |
| MP PENSJON PK | 2.6% | 680340.000000 | 2025 |
| UBS SWITZERLAND AG | 2.1% | 551304.000000 | 2025 |
| CGS HOLDING AS | 1.9% | 506787.000000 | 2025 |
| NORDA ASA | 1.7% | 438680.000000 | 2025 |
| STAVERN HELSE OG FORVALTNING AS | 1.5% | 400000.000000 | 2025 |
| SUNDT AS | 1.3% | 341938.000000 | 2025 |
| RADFORSK INVESTERINGSSTIFTELSE | 1.2% | 316123.000000 | 2025 |
| JAKOB HATTELAND HOLDING AS | 1.2% | 313394.000000 | 2025 |
| KVANTIA AS | 1.0% | 255862.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| ZELLUNA IMMUNOTHERAPY AS | Active | 100.0% | 13524826.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.